Tag: Krystal Biotech

The biotechnology sector has a standout performer demonstrating how strategic achievements and impressive quarterly results can propel equity values to ...

Krystal Biotech has delivered a stunning quarterly report that significantly surpassed market projections, demonstrating both robust commercial execution and strategic ...

Gene therapy specialist Krystal Biotech has achieved a significant regulatory milestone that is driving substantial investor interest. The company's flagship ...

Krystal Biotech finds itself at a critical juncture this week as market participants weigh recent operational successes against emerging challenges. ...

Krystal Biotech is implementing a significant strategic pivot in response to recent regulatory developments at the U.S. Food and Drug ...

Krystal Biotech is executing a significant strategic shift in its oncology development program, abandoning one promising approach to concentrate resources ...